Kovo Health Tech - Senior VP of Finance, Mark Detz
Senior VP of Finance, Mark Detz
Source: Newsfile Corp.
  • Kovo HealthTech (KOVO) has appointed Mark Detz, CPA, CA as Senior Vice President of Finance
  • Mark previously held several senior positions with Anheuser-Busch and holds an undergraduate degree from the Schulich School of Business
  • Kovo HealthTech is a growing healthcare technology company that specializes in billing-as-a-service
  • Kovo HealthTech Corporation (KOVO) opened trading at C$0.39 per share

Kovo HealthTech (KOVO) has appointed veteran finance expert Mark Detz, CPA, CA as its Senior Vice President of Finance.

Before joining Kovo, Detz held several senior positions with Anheuser-Busch, where he focused on strategy and financial operations, including financial reporting, forecasting, budgeting, mergers and acquisitions. Detz began his career as an auditor at KPMG and holds an undergraduate degree from the Schulich School of Business.

“As we look to continue to scale our business operations in 2022 through strategic acquisitions and organic growth, we’re excited to welcome Mark to the Kovo team,” says Kovo CFO Inder Saini.

“Mark’s entrepreneurial, disciplined approach and track-record with world-leading innovators like Anheuser-Busch and KPMG, will be instrumental in driving Kovo’s aggressive 2022 growth strategy,” he explains.

Kovo HealthTech is a growing healthcare technology company that specializes in billing-as-a-service.

The company helps healthcare providers seamlessly digitally track and manage complex patient care registration, services, billing, and payments using its proprietary OneRev technology platform.

Kovo HealthTech Corporation (KOVO) opened trading at C$0.39 per share.

More From The Market Online

KWESST to provide situational awareness for the Canadian Red Cross

KWESST Micro Systems (TSXV:KWE) wins a contract to provide a situational awareness app to support the Canadian Red Cross.

Reliq Health expands contract with U.S. health group

Reliq Health Technologies (TSXV:RHT) reveals it has expanded an existing contract with a large U.S. health group.